ENZON PHARMACEUTICALS INC. (ENZN) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-24
4:14 pm
Unchanged
2025-10-2413DEnzon Pharmaceuticals, Inc.
ENZN
CARL C ICAHN36,056,636
48.600%
0
(Unchanged)
Filing
History
2025-06-23
08:19 am
Unchanged
2025-06-2013DEnzon Pharmaceuticals, Inc.
ENZN
CARL C ICAHN36,056,636
48.600%
0
(Unchanged)
Filing
History
2024-12-19
4:30 pm
Purchase
2024-12-1913DEnzon Pharmaceuticals, Inc.
ENZN
CARL C ICAHN36,056,636
48.600%
36,056,636increase
(New Position)
Filing
History
2024-08-19
5:47 pm
Sale
2024-08-1913DEnzon Pharmaceuticals, Inc.
ENZN
CARL C ICAHN0
0.000%
-36,056,636decrease
(Position Closed)
Filing
History